We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

34 hedge funds and large institutions have $2.08M invested in 9 Meters Biopharma in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 39 → 34 (-5)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

53% less capital invested

Capital invested by funds: $4.4M → $2.08M (-$2.32M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
34
Holders Change
-5
Holders Change %
-12.82%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
7
Closed
8
Calls
$807K
Puts
–
Net Calls
+$807K
Net Calls Change
-$829K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$15.1K
2
TSS
Two Sigma Securities
New York
+$12.2K
3
Group One Trading
Group One Trading
Illinois
+$4.42K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$756

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$57.7K
2
HF
HRT Financial
New York
-$25K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$22.6K
4
Millennium Management
Millennium Management
New York
-$21K
5
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
26
Strategic Investment Solutions
Illinois
$194 – – –
MA
27
MCF Advisors
Kentucky
$185 – – –
BCMLT
28
Beacon Capital Management LLC (Tennessee)
Tennessee
$104 – – –
PNC Financial Services Group
29
PNC Financial Services Group
Pennsylvania
$101 – – –
RFA
30
Register Financial Advisors
Georgia
$67 – – –
Fidelity Investments
31
Fidelity Investments
Massachusetts
$36 +$47 +53 New
JP Morgan Chase
32
JP Morgan Chase
New York
$5 – – –
RCM
33
Raleigh Capital Management
North Carolina
$1 – – –
HF
34
HRT Financial
New York
– -$25K -18,249 Closed
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
– -$22.6K -16,264 Closed
Millennium Management
36
Millennium Management
New York
– -$21K -15,326 Closed
Mercer Global Advisors
37
Mercer Global Advisors
Colorado
– -$14K -10,250 Closed
UBS Group
38
UBS Group
Switzerland
– -$6.03K -4,340 Closed
HFM
39
Hartford Financial Management
Connecticut
– -$278 -200 Closed
TWA
40
TCI Wealth Advisors
Arizona
– -$70 -50 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$27 -31 -19%
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
– -$3 -2 Closed
1
2

NMTR Hedge Fund Activity: Q2 2023 in Review

34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q2 2023, worth a combined $2.08M — down 53% from $4.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NMTR and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $15.1K. The largest seller was Sabby Management, cutting an estimated $57.7K.

  • 34 institutional investors held 9 Meters Biopharma (NMTR) as of Q2 2023, down from 39 in Q1 2023.
  • Funds reported $2.08M of 9 Meters Biopharma stock for Q2 2023, down 53% quarter-over-quarter.
  • 3 funds opened new 9 Meters Biopharma positions in Q2 2023 and 8 closed out, a net change of -5 holders.
  • The largest 9 Meters Biopharma buyer in Q2 2023 was Susquehanna International Group, an estimated $15.1K added.
  • The largest 9 Meters Biopharma seller in Q2 2023 was Sabby Management, an estimated $57.7K sold.

Based on aggregated 13F filings for Q2 2023.